Banking firm CIB has launched a corporate venturing division targeting early-stage fintech businesses in Egypt, Africa and the Middle East.
Author: Callum Cyrus
News round up 24 December 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Annexon annexes $75m in series C funding
Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.
Corporates identify 4Paradigm in $145m series C
4Paradigm has now won backing from a host of corporates for its technology, which helps clients build AI apps for purposes including financial services.
VoxelCloud passes series B test with $50m
Tencent-backed medical diagnostics technology developer VoxelCloud has now raised $78.5m in total, Shenzhen Hongtai Capital Management having led its latest round.
Corporates help switch on $29m industry fund
Shanghai Electric will invest $9.9m in the fund, which is targeting AI and smart manufacturing industries, while a Golden Concord subsidiary is putting up $10.2m.
News round up 17 December 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Walker catches Procter & Gamble’s eye
GV has exited POC-focused health and beauty product manufacturer Walker and Company in an acquisition of undisclosed size by Procter & Gamble.
Pharma’s story of external innovation
Pharma CVCs have achieved an impressive exit record on the back of successes balancing tools in the innovation toolkit over the past 20 years
Mitsubishi subscribes to AP Ventures
Mitsubishi joins Anglo American Platinum in a second AP Ventures that will fund companies harnessing platinum group metals.
Celect celebrates $15m series C
NGP Partners led retail analytics software provider Celect’s series C round, which included Fung Capital and existing investors Activant Capital and August Capital.
Orbs absorbs Kakao funding
Blockchain technology developer Orbs has added some $15.4m in cryptocurrency to the $118m it raised in May, and expects the funding to last seven years.
Corporates help complete Mission Bio’s series B round
Agilent and Lam Research participated in a $30m round for UCSF’s DNA analysis spinout, Mission Bio, whose existing shareholders include Stanford-StartX Fund.
HubSpot finds room for $30m fund
Enterprise software producer HubSpot has unveiled a corporate venturing fund that will make strategic investments in software-as-a-service developers.